Agilon Health Inc (NYSE:AGL) has a beta value of 0.67 and has seen 0.9 million shares traded in the recent trading session. The company, currently valued at $1.41B, closed the recent trade at $3.41 per share which meant it lost -$0.01 on the day or -0.28% during that session. The AGL stock price is -126.69% off its 52-week high price of $7.73 and 56.01% above the 52-week low of $1.50. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.96 million shares traded. The 3-month trading volume is 4.16 million shares.
The consensus among analysts is that Agilon Health Inc (AGL) is Buy stock at the moment, with a recommendation rating of 2.86. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 3 out of 10 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight.
Agilon Health Inc (NYSE:AGL) trade information
Sporting -0.28% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the AGL stock price touched $3.41 or saw a rise of 7.34%. Year-to-date, Agilon Health Inc shares have moved 79.50%, while the 5-day performance has seen it change 3.66%. Over the past 30 days, the shares of Agilon Health Inc (NYSE:AGL) have changed 15.22%. Short interest in the company has seen 20.24 million shares shorted with days to cover at 3.77.
Wall Street analysts have a consensus price target for the stock at $2.75, which means that the shares’ value could drop -24.0% from the levels at last check today. The projected low price target is $2.5 while the price target rests at a high of $3.0. In that case, then, we find that the latest price level in today’s session is 12.02% off the targeted high while a plunge would see the stock lose 26.69% from the levels at last check today.
Agilon Health Inc (AGL) estimates and forecasts
The company’s shares have lost -30.68% over the past 6 months. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 7.65% over the past 5 years. Earnings growth for 2025 is a modest -15.75% while over the next 5 years, the company’s earnings are expected to increase by 24.06%.
AGL Dividends
Agilon Health Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Agilon Health Inc (NYSE:AGL)’s Major holders
Insiders own 1.82% of the company shares, while shares held by institutions stand at 101.56% with a share float percentage of 103.44%. Investors are also buoyed by the number of investors in a company, with Agilon Health Inc having a total of 260.0 institutions that hold shares in the company. The top two institutional holders are CLAYTON, DUBILIER & RICE, LLC with over 100.0 million shares worth more than $654.0 million. As of 2024-06-30, CLAYTON, DUBILIER & RICE, LLC held 24.3149% of shares outstanding.
The other major institutional holder is FMR LLC, with the holding of over 56.93 million shares as of 2024-06-30. The firm’s total holdings are worth over $372.3 million and represent 13.8418% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Specialized-Health Care Fund and Smallcap World Fund. As of Oct 31, 2024, the former fund manager holds about 9.39% shares in the company for having 38.68 shares of worth $131.51 million while later fund manager owns 23.57 shares of worth $80.14 million as of Sep 30, 2024, which makes it owner of about 5.72% of company’s outstanding stock.
